Regulation of the MDR1 promoter by E2F1 and EAPP

FEBS Letters

Volumn 587, Issue 10, 2013, Pages 1504-1509

  Andorfer, Peter ^a   Rotheneder, Hans ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Chemotherapy; E2F1; EAPP; Gene promoter; Multidrug resistance; P glycoprotein

Indexed keywords

EAPP PROTEIN; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PHOSPHOPROTEIN; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MDR1 GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TUMOR CELL; UPREGULATION;

ANTINEOPLASTIC AGENTS; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; E2F1 TRANSCRIPTION FACTOR; ETOPOSIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; P-GLYCOPROTEIN; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 84877787758     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.03.026     Document Type: Article

References (46)

1. R.K. Jain Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function J. Control. Release 74 2001 7 25
2. A. Pluen Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors Proc. Natl. Acad. Sci. USA 98 2001 4628 4633
3. M.M. Gottesman, T. Fojo, and S.E. Bates Multidrug resistance in cancer: role of ATP-dependent transporters Nat. Rev. Cancer 2 2002 48 58
4. A.H. Schinkel Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs Cell 77 1994 491 502
5. J.A. Bush, and G. Li Cancer chemoresistance: the relationship between p53 and multidrug transporters Int. J. Cancer 98 2002 323 330
6. K.V. Chin, K. Ueda, I. Pastan, and M.M. Gottesman Modulation of activity of the promoter of the human MDR1 gene by Ras and p53 Science 255 1992 459 462
7. K.T. Nguyen, B. Liu, K. Ueda, M.M. Gottesman, I. Pastan, and K.V. Chin Transactivation of the human multidrug resistance (MDR1) gene promoter by p53 mutants Oncol. Res. 6 1994 71 77
8. G.F. Sullivan, J.M. Yang, A. Vassil, J. Yang, J. Bash-Babula, and W.N. Hait Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cells J. Clin. Invest. 105 2000 1261 1267
9. S. Labialle, L. Gayet, E. Marthinet, D. Rigal, and L.G. Baggetto Transcriptional regulators of the human multidrug resistance 1 gene: recent views Biochem. Pharmacol. 64 2002 943 948
10. E.K. Baker, and A. El-Osta MDR1, chemotherapy and chromatin remodeling Cancer Biol. Ther. 3 2004 819 824
11. A. Blais, and B.D. Dynlacht Hitting their targets: an emerging picture of E2F and cell cycle control Curr. Opin. Genet. Dev. 14 2004 527 532
12. M. Novy, R. Pohn, P. Andorfer, T. Novy-Weiland, B. Galos, L. Schwarzmayr, and H. Rotheneder EAPP, a novel E2F binding protein that modulates E2F-dependent transcription Mol. Biol. Cell 16 2005 2181 2190
13. L. Schwarzmayr, P. Andorfer, M. Novy, and H. Rotheneder Regulation of the E2F-associated phosphoprotein promoter by GC-box binding proteins Int. J. Biochem. Cell Biol. 40 2008 2845 2853
14. P. Andorfer, and H. Rotheneder EAPP: gatekeeper at the crossroad of apoptosis and p21-mediated cell-cycle arrest Oncogene 30 2011 2679 2690
15. K. Chen, X.M. Ou, J.B. Wu, and J.C. Shih Transcription factor E2F-associated phosphoprotein (EAPP), RAM2/CDCA7L/JPO2 (R1), and simian virus 40 promoter factor 1 (Sp1) cooperatively regulate glucocorticoid activation of monoamine oxidase B Mol. Pharmacol. 79 2011 308 317
16. P. Andorfer, L. Schwarzmayr, and H. Rotheneder EAPP modulates the activity of p21 and Chk2 Cell Cycle 10 2011 2077 2082
17. J. Lukas, C.S. Sorensen, C. Lukas, E. Santoni-Rugiu, and J. Bartek P16INK4a, but not constitutively active pRb, can impose a sustained G1 arrest: molecular mechanisms and implications for oncogenesis Oncogene 18 1999 3930 3935
18. T. Okamoto, H. Izumi, T. Imamura, H. Takano, T. Ise, T. Uchiumi, M. Kuwano, and K. Kohno Direct interaction of p53 with the Y-Box binding protein, YB-1: a mechanism for regulation of human gene expression Oncogene 19 2000 6194 6202
19. M. Bieda, X. Xu, M.A. Singer, R. Green, and P.J. Farnham Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome Genome Res. 16 2006 595 605
20. A.R. Cao, R. Rabinovich, M. Xu, X. Xu, V.X. Jin, and P.J. Farnham Genome-wide analysis of transcription factor E2F1 mutant proteins reveals that N- and C-terminal protein interaction domains do not participate in targeting E2F1 to the human genome J. Biol. Chem. 286 2011 11985 11996
21. K. Kohno, H. Izumi, T. Uchiumi, M. Ashizuka, and M. Kuwano The pleiotropic functions of the Y-box-binding protein, YB-1 Bioessays 25 2003 691 698
22. S. Jin, and K.W. Scotto Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y Mol. Cell. Biol. 18 1998 4377 4384
23. Y. Qian, C. Luckey, L. Horton, M. Esser, and D.J. Templeton Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding Mol. Cell. Biol. 12 1992 5363 5372
24. S.W. Hiebert, S.P. Chellappan, J.M. Horowitz, and J.R. Nevins The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F Genes Dev. 6 1992 177 185
25. G.D. Leonard, T. Fojo, and S.E. Bates The role of ABC transporters in clinical practice Oncologist 8 2003 411 424
26. G. Szakacs, J.K. Paterson, J.A. Ludwig, C. Booth-Genthe, and M.M. Gottesman Targeting multidrug resistance in cancer Nat. Rev. Drug Discov. 5 2006 219 234
27. K. Goda, Z. Bacso, and G. Szabo Multidrug resistance through the spectacle of P-glycoprotein Curr. Cancer Drug Targets 9 2009 281 297
28. M.K. Leong, H.B. Chen, and Y.H. Shih Prediction of promiscuous P-glycoprotein inhibition using a novel machine learning scheme PLoS ONE 7 2012 e33829
29. H. Zhu, H. Wu, X. Liu, B.R. Evans, D.J. Medina, C.G. Liu, and J.M. Yang Role of microRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells Biochem. Pharmacol. 76 2008 582 588
30. Yang, L., Li, N., Wang, H., Jia, X., Wang, X., and Luo, J. (2012) Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance. Oncol. Rep. 28 (2), 592-600.
31. L. Bao, S. Hazari, S. Mehra, D. Kaushal, K. Moroz, and S. Dash Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298 Am. J. Pathol. 180 2012 2490 2503
32. P.D. Adams, and W.G. Kaelin Jr. The cellular effects of E2F overexpression Curr. Top. Microbiol. Immunol. 208 1996 79 93
33. K. Alevizopoulos, J. Vlach, S. Hennecke, and B. Amati Cyclin E and C Myc promote cell proliferation in the presence of P16(Ink4a) and of hypophosphorylated retinoblastoma family proteins EMBO J. 16 17 1997 5322 5333
34. G. Leone Myc requires distinct E2F activities to induce S phase and apoptosis Mol. Cell 8 2001 105 113
35. S. Hong, R.V. Pusapati, J.T. Powers, and D.G. Johnson Oncogenes and the DNA damage response: Myc and E2F1 engage the ATM signaling pathway to activate p53 and induce apoptosis Cell Cycle 5 2006 801 803
36. W.C. Lin, F.T. Lin, and J.R. Nevins Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation Genes Dev. 15 2001 1833 1844
37. T.F. Kowalik, J. DeGregori, J.K. Schwarz, and J.R. Nevins E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis J. Virol. 69 1995 2491 2500
38. H. Pan, C. Yin, N.J. Dyson, E. Harlow, L. Yamasaki, and T. Van Dyke Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors Mol. Cell 2 1998 283 292
39. M. Urist, T. Tanaka, M.V. Poyurovsky, and C. Prives p73 Induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2 Genes Dev. 18 2004 3041 3054
40. H.A. Rogoff, M.T. Pickering, F.M. Frame, M.E. Debatis, Y. Sanchez, S. Jones, and T.F. Kowalik Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2 Mol. Cell. Biol. 24 2004 2968 2977
41. M. Asada, T. Yamada, H. Ichijo, D. Delia, K. Miyazono, K. Fukumuro, and S. Mizutani Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation EMBO J. 18 1999 1223 1234
42. E.V. Broude, Z.N. Demidenko, C. Vivo, M.E. Swift, B.M. Davis, M.V. Blagosklonny, and I.B. Roninson p21 (CDKN1A) is a negative regulator of p53 stability Cell Cycle 6 2007 1468 1471
43. C. Guo, S. Yu, A.T. Davis, H. Wang, J.E. Green, and K. Ahmed A potential role of nuclear matrix-associated protein kinase CK2 in protection against drug-induced apoptosis in cancer cells J. Biol. Chem. 276 2001 5992 5999
44. Z. Hu, S. Jin, and K.W. Scotto Transcriptional activation of the MDR1 gene by UV irradiation. Role of NF-Y and Sp1 J. Biol. Chem. 275 2000 2979 2985
45. S.Y. Lin, A.R. Black, D. Kostic, S. Pajovic, C.N. Hoover, and J.C. Azizkhan Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction Mol. Cell. Biol. 16 1996 1668 1675
46. J. Karlseder, H. Rotheneder, and E. Wintersberger Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F Mol. Cell. Biol. 16 1996 1659 1667